 Toni Nagy
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 6 | 2011 | 42 | 1.210 |
Why?
| | Salmonella typhimurium | 7 | 2022 | 183 | 1.150 |
Why?
| | Macrophages | 8 | 2020 | 1543 | 1.090 |
Why?
| | Salmonella Infections, Animal | 6 | 2019 | 38 | 1.040 |
Why?
| | Salmonella enterica | 2 | 2020 | 57 | 0.760 |
Why?
| | Bacterial Proteins | 7 | 2023 | 898 | 0.660 |
Why?
| | Clofazimine | 1 | 2020 | 14 | 0.650 |
Why?
| | Epithelial Cells | 3 | 2011 | 1103 | 0.640 |
Why?
| | Anti-Bacterial Agents | 6 | 2022 | 1811 | 0.580 |
Why?
| | Cation Transport Proteins | 3 | 2016 | 109 | 0.550 |
Why?
| | Membrane Transport Proteins | 3 | 2018 | 154 | 0.490 |
Why?
| | Iron | 2 | 2015 | 324 | 0.460 |
Why?
| | Antigens, Bacterial | 4 | 2011 | 125 | 0.440 |
Why?
| | NLR Proteins | 2 | 2025 | 8 | 0.440 |
Why?
| | Virulence Factors | 2 | 2013 | 160 | 0.430 |
Why?
| | Enterobactin | 1 | 2013 | 8 | 0.410 |
Why?
| | Stomach Neoplasms | 4 | 2011 | 117 | 0.410 |
Why?
| | Bacteriophages | 2 | 2025 | 98 | 0.390 |
Why?
| | Helicobacter Infections | 2 | 2011 | 30 | 0.370 |
Why?
| | PPAR delta | 1 | 2011 | 5 | 0.360 |
Why?
| | Gram-Negative Bacteria | 2 | 2022 | 76 | 0.350 |
Why?
| | Escherichia coli | 3 | 2025 | 827 | 0.320 |
Why?
| | Virulence | 4 | 2014 | 265 | 0.290 |
Why?
| | Eosinophils | 1 | 2011 | 322 | 0.290 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 368 | 0.260 |
Why?
| | Adenocarcinoma | 2 | 2011 | 882 | 0.260 |
Why?
| | Bacteria | 3 | 2023 | 868 | 0.240 |
Why?
| | Cells, Cultured | 5 | 2020 | 4182 | 0.220 |
Why?
| | Cell Movement | 3 | 2016 | 969 | 0.210 |
Why?
| | Spleen | 3 | 2015 | 524 | 0.210 |
Why?
| | Molecular Chaperones | 1 | 2025 | 196 | 0.200 |
Why?
| | Escherichia coli Proteins | 1 | 2025 | 200 | 0.200 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2022 | 61 | 0.200 |
Why?
| | Animals | 17 | 2023 | 37243 | 0.190 |
Why?
| | Cardiolipins | 1 | 2022 | 84 | 0.180 |
Why?
| | Salmonella Infections | 1 | 2022 | 55 | 0.180 |
Why?
| | Mice | 9 | 2022 | 17828 | 0.180 |
Why?
| | Gastric Mucosa | 2 | 2011 | 53 | 0.170 |
Why?
| | Cell Membrane | 2 | 2022 | 716 | 0.170 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2020 | 47 | 0.170 |
Why?
| | Apoptosis | 1 | 2009 | 2551 | 0.160 |
Why?
| | Signal Transduction | 2 | 2011 | 5092 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 183 | 0.150 |
Why?
| | Immunity, Innate | 2 | 2023 | 825 | 0.140 |
Why?
| | Gerbillinae | 4 | 2011 | 65 | 0.140 |
Why?
| | Dipeptides | 1 | 2018 | 51 | 0.140 |
Why?
| | Bacterial Load | 1 | 2018 | 68 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2018 | 94 | 0.130 |
Why?
| | Superoxides | 1 | 2017 | 217 | 0.130 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 157 | 0.130 |
Why?
| | Drug Resistance, Bacterial | 1 | 2017 | 184 | 0.120 |
Why?
| | Lipid Metabolism | 1 | 2019 | 523 | 0.120 |
Why?
| | Meningitis | 1 | 2016 | 81 | 0.120 |
Why?
| | Liver | 2 | 2014 | 1807 | 0.120 |
Why?
| | Gene Deletion | 2 | 2013 | 389 | 0.110 |
Why?
| | Siderophores | 1 | 2014 | 12 | 0.110 |
Why?
| | Monocytes | 1 | 2016 | 573 | 0.100 |
Why?
| | Anemia | 1 | 2015 | 175 | 0.100 |
Why?
| | Gastritis | 2 | 2011 | 110 | 0.100 |
Why?
| | Trehalose | 1 | 2012 | 32 | 0.090 |
Why?
| | Betaine | 1 | 2012 | 64 | 0.090 |
Why?
| | beta Catenin | 2 | 2011 | 253 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2011 | 333 | 0.090 |
Why?
| | Catenins | 1 | 2011 | 6 | 0.090 |
Why?
| | Cyclin E | 1 | 2011 | 25 | 0.090 |
Why?
| | Oncogene Proteins | 1 | 2011 | 58 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2011 | 111 | 0.090 |
Why?
| | Interferon-gamma | 1 | 2014 | 787 | 0.090 |
Why?
| | Mammals | 2 | 2022 | 285 | 0.080 |
Why?
| | Coculture Techniques | 1 | 2011 | 241 | 0.080 |
Why?
| | Cell Line | 2 | 2013 | 2879 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2010 | 442 | 0.080 |
Why?
| | Biological Transport | 2 | 2022 | 403 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 322 | 0.070 |
Why?
| | Stomach | 1 | 2009 | 109 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 450 | 0.070 |
Why?
| | Risk | 1 | 2011 | 913 | 0.070 |
Why?
| | Gene Silencing | 1 | 2009 | 196 | 0.070 |
Why?
| | Drug Resistance, Multiple, Bacterial | 2 | 2018 | 74 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 850 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 665 | 0.060 |
Why?
| | Microbial Sensitivity Tests | 2 | 2018 | 348 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3397 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2010 | 527 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4316 | 0.060 |
Why?
| | Proteome | 1 | 2009 | 471 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2025 | 93 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2480 | 0.050 |
Why?
| | Humans | 10 | 2025 | 138972 | 0.050 |
Why?
| | Mutation | 1 | 2014 | 3984 | 0.050 |
Why?
| | Cytokines | 1 | 2011 | 2083 | 0.050 |
Why?
| | Phagosomes | 1 | 2022 | 44 | 0.050 |
Why?
| | Amines | 1 | 2022 | 40 | 0.050 |
Why?
| | Glycerophospholipids | 1 | 2022 | 34 | 0.050 |
Why?
| | Proteomics | 1 | 2009 | 1112 | 0.050 |
Why?
| | Inflammasomes | 1 | 2023 | 133 | 0.050 |
Why?
| | Liposomes | 1 | 2022 | 218 | 0.040 |
Why?
| | Membrane Lipids | 1 | 2020 | 91 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2591 | 0.040 |
Why?
| | Microbial Viability | 1 | 2019 | 91 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 888 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5801 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2016 | 54 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 122 | 0.030 |
Why?
| | Ataxia | 1 | 2016 | 70 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2016 | 108 | 0.030 |
Why?
| | Amino Acids | 1 | 2019 | 497 | 0.030 |
Why?
| | Encephalitis | 1 | 2016 | 136 | 0.030 |
Why?
| | Duodenum | 1 | 2015 | 74 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 1031 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 787 | 0.030 |
Why?
| | Bacteremia | 1 | 2016 | 214 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 328 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1076 | 0.030 |
Why?
| | Male | 4 | 2015 | 68250 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1730 | 0.020 |
Why?
| | Salinity | 1 | 2012 | 19 | 0.020 |
Why?
| | Salts | 1 | 2012 | 37 | 0.020 |
Why?
| | Nanoparticles | 1 | 2017 | 469 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 557 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 332 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 66 | 0.020 |
Why?
| | Flagellin | 1 | 2009 | 17 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 112 | 0.020 |
Why?
| | Female | 2 | 2015 | 74016 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 143 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2009 | 157 | 0.020 |
Why?
| | Adhesins, Bacterial | 1 | 2008 | 40 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2008 | 103 | 0.020 |
Why?
| | Bacterial Adhesion | 1 | 2008 | 102 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2009 | 335 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2815 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1232 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2008 | 321 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2791 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 33782 | 0.000 |
Why?
| | Adult | 1 | 2008 | 38393 | 0.000 |
Why?
|
|
Nagy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|